COVID Olfactory Trial Hints at Possible Benefit
5 (319) · € 10.00 · En stock
Small sample size limits significance of findings
Mixed results for nasal theophylline to treat COVID-related loss of smell
Neuromodulation for COVID-19 update 7: Electronic noses, NIH “RECOVER” recruits' patients, New prospects., News
Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes - ScienceDirect
Anosmia and loss of smell in the era of covid-19
New Findings Help Make Sense of Brain Fog From Long COVID
Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments
SARS-CoV-2 Antigen Levels Linked to Patient Outcomes NIAID: National Institute of Allergy and Infectious Diseases
Dietary supplements and herbal medicine for COVID-19: A systematic review of randomized control trials - Clinical Nutrition ESPEN
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial - eClinicalMedicine
Diagnostics, Free Full-Text
Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers - eClinicalMedicine
Frontiers Post-traumatic olfactory dysfunction: a scoping review of assessment and rehabilitation approaches
Persistent olfactory learning deficits during and post-COVID-19 infection - ScienceDirect
